| Product Name | NebuSelect™ Recombinant Biotinylated Human TFPI, Avi-His-tag |
|---|---|
| Catalog Number | NBL-242039 |
| Alias/Synonyms | TFPI; LACI; TFPI1; EPI; TFI; convertin; TFPI |
| Appearance | see COA |
| Molecule Weight | Asp29-Lys282 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | P10646-1 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-242039-100ug | 100ug | Inquire | Inquire | |
| NBL-242039-1mg | 1mg | Inquire | Inquire | |
| NBL-242039-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Biotinylated Human TFPI, Avi-His-tag
Catalog#:
NBL-242039
Description:
NebuSelect™ Recombinant Biotinylated Human TFPI, Avi-His-tag(Cat#NBL-242039) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Asp29-Lys282.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 32.1 kDa. Due to glycosylation, the protein migrates to 40-50 kDa based on Bis-Tris PAGE result.
Target Name:
TFPI; LACI; TFPI1; EPI; TFI; convertin; TFPI
Target Information:
Oestrogens influence the pathophysiology and development of hormone-sensitive cancers, such as breast cancer. Tissue factor pathway inhibitor (TFPI) is a serine protease inhibitor of the extrinsic coagulation pathway and has recently been associated with breast cancer cell development.
Amino Acid Sequence:
Asp29-Lys282
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.